Stock BHVN BIOHAVEN LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Biohaven Ltd.

Equities

BHVN

VGG1110E1079

End-of-day quote Nyse
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
35.1 USD -0.37% Intraday chart for Biohaven Ltd. -4.41% -17.99%
May. 29 Biohaven Ltd. Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas Including Immunology, Neuroscience, Metabolic Disorders and Oncology At Annual Investor R&D Day CI
May. 29 Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate BHV-1510 in Advanced or Metastatic Epithelial Tumors CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Bullish

Resistance 38.33 59.75 57.97
Spread/Res.-8.43%-41.26%-39.45%
Spread/Supp.+12.36%+12.36%+13.89%
Support 31.24 31.24 30.82

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. BHVN Stock
  4. Charts Biohaven Ltd.